Last reviewed · How we verify
NCT05917067: FLUOPATCH
Fluorescence Imaging of the Parathyroid Glands of Children
trial testing Fluorescence imaging of the parathyroid glands of children in Childhood Thyroid Gland Carcinoma in 23 participants. Completed in 1 December 2024.
1 October 2024
Quick facts
| Lead sponsor | Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 1 September 2023 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 3 locations across Netherlands |
Drugs / interventions tested
- Fluorescence imaging of the parathyroid glands of children
Conditions studied
- Childhood Thyroid Gland Carcinoma — all drugs for Childhood Thyroid Gland Carcinoma →
- Thyroid Diseases — all drugs for Thyroid Diseases →
Sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Who can join
Under 18, any sex, with Childhood Thyroid Gland Carcinoma or Thyroid Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop a standardized and user-independent imaging workflow model for autofluorescence and quantified fluorescence angiography with Indocyanine Green (ICG) of the parathyroid glands of children. For this purpose, all pediatric patients will undergo thyroid surgery with the use of autofluorescence and quantified ICG-fluorescence. This study could be the first step in reducing the rate of postoperative hypocalcemia in children, by using fluorescence angiography during pediatric thyroid surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Quantified Fluorescence Imaging for the Detection and Perfusion of the Parathyroid Glands of Children (FLUOPATCH): Study Protocol for a Proof-of-Concept Study
de Berg DJv, Kruijff S, Trotsenburg APv, Santen HMv, et al · · 2024 · DOI 10.21203/rs.3.rs-4840337/v1
Verify or expand the search:
- PubMed search for NCT05917067
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) trials
Trials by the same sponsor.
- NCT07165145 — Effect of Agricultural Practices on Crops, Gut Microbiome, and Human Health · NA · recruiting
- NCT06079970 — Confocal Laser Endomicroscopy VERification · NA · recruiting
- NCT05686330 — Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable (Apple Watch) · NA · completed
- NCT06178822 — Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05917067 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
- Last refreshed: 30 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917067.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing